| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |